Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Patriarca

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Pediatrics|April 1, 1986
Efficacy of acellular pertussis vaccineP A Patriarca, E W Brink, W A Orenstein, et al.
Emerging Infectious Diseases|April 30, 1999
Preparing for pandemic influenza: the need for enhanced surveillanceK F Gensheimer, K Fukuda, L Brammer, et al.
Vaccine|February 1, 2011
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of ageR Baxter, P A Patriarca, K Ensor, et al.
Public Health Reports (Washington, D.C. : 1974)|September 1, 1982
Pneumococcal vaccination practices among private physiciansP A Patriarca, W F Schlech, A R Hinman, et al.
Bulletin of the World Health Organization|January 1, 1991
Principles of measles controlF T Cutts, R H Henderson, C J Clements, et al.
Archives of Internal Medicine|September 1, 1986
Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenzaW L Atkinson, N H Arden, P A Patriarca, et al.
The New England Journal of Medicine|June 30, 1983
Influenza vaccination and warfarin or theophylline toxicity in nursing-home residentsP A Patriarca, A P Kendal, R L Stricof, et al.
The Journal of Infectious Diseases|April 1, 1986
Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderlyN H Arden, P A Patriarca, K J Lui, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1984
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homesP A Patriarca, N A Kater, A P Kendal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Epidemiological features of pertussis in the United States, 1980-1989K M Farizo, S L Cochi, E R Zell, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Pediatrics|April 1, 1986
Efficacy of acellular pertussis vaccineP A Patriarca, E W Brink, W A Orenstein, et al.
Emerging Infectious Diseases|April 30, 1999
Preparing for pandemic influenza: the need for enhanced surveillanceK F Gensheimer, K Fukuda, L Brammer, et al.
Vaccine|February 1, 2011
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of ageR Baxter, P A Patriarca, K Ensor, et al.
Public Health Reports (Washington, D.C. : 1974)|September 1, 1982
Pneumococcal vaccination practices among private physiciansP A Patriarca, W F Schlech, A R Hinman, et al.
Bulletin of the World Health Organization|January 1, 1991
Principles of measles controlF T Cutts, R H Henderson, C J Clements, et al.
Archives of Internal Medicine|September 1, 1986
Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenzaW L Atkinson, N H Arden, P A Patriarca, et al.
The New England Journal of Medicine|June 30, 1983
Influenza vaccination and warfarin or theophylline toxicity in nursing-home residentsP A Patriarca, A P Kendal, R L Stricof, et al.
The Journal of Infectious Diseases|April 1, 1986
Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderlyN H Arden, P A Patriarca, K J Lui, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1984
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homesP A Patriarca, N A Kater, A P Kendal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Epidemiological features of pertussis in the United States, 1980-1989K M Farizo, S L Cochi, E R Zell, et al.
Pageof 8